Moscoe brings extensive experience in life sciences and biotech,
as well as thought leadership and a background in international
business, to benefit Tunnell clients.
BERWYN, Pa. ,
July 1,
2024 /PRNewswire-PRWeb/ -- Tunnell, an employee-owned
company that provides expert talent and consulting services to the
Life Sciences industry, announced today that Steven Moscoe has joined the firm as its newest
Principal.
Moscoe's diverse range of experience
includes analysis of the impact of R&D, advanced therapy
manufacturing and clinical and commercial projects on
profitability, as well as identification of opportunities to expand
services and collaborations.
"Over the course of my career, I have had an opportunity to work
with clients to identify some of the industry's biggest challenges
and to bring unique solutions to the table," said Moscoe. "Today as
I embark on my new mission, I look forward to bringing expertise
and insights to Tunnell Consulting's clients, and to work closely
with the entire Tunnell team to create the best solutions for our
clients."
Moscoe's diverse range of experience includes analysis of the
impact of R&D, advanced therapy manufacturing and clinical and
commercial projects on profitability, as well as identification of
opportunities to expand services and collaborations. Additionally,
his background as a Lean/Six Sigma practitioner has allowed him to
provide insights for decision-making and execution across multiple
projects. To further build on that strong foundation, Moscoe's
communication and change management skills will prove essential in
building strong and lasting partnerships with key stakeholders,
clients and leadership.
Over his career, his projects have included leading program
management for the build-out of a state-of-the-art CAR-T cell
therapy manufacturing plant, managing complex programs for large
pharmaceutical companies, and delivering projects across the U.S.,
Canada, Europe, LATAM, Asia and India.
Most recently Moscoe worked with life sciences venture capital
(VC) and private equity (PE) clients delivering operational
improvements for their portfolio companies, as well as providing
buy and sell-side due diligence services. He has led multiple
projects involving Contract Development & Manufacturing
Organizations (CDMOs), Contract Research Organizations (CROs), and
Contract Packaging Organizations (CPOs), serving sponsor companies,
contract organizations, and PE firms.
A respected thought leader who is published in the industry's
leading journals, Moscoe earned his International MBA with Finance
and French Business specialization at University of South Carolina, and his Bachelor of
Business Administration at University of
Kentucky. He has multiple certifications, including
Certified Lean Practitioner, Six Sigma Black Belt, and Project
Management Professional (PMP), as well as professional
certifications from Emory, MIT, and
Wharton.
About Tunnell Consulting
For over 60 years, Tunnell has provided both expert talent and
consulting services to clients including Biopharmas, CDMOs, the US
Government, incubators, investors and NGOs. We have experience
across multiple platforms – including large molecule, vaccines,
cell and gene therapy and small molecule – and our subject matter
expertise focuses on regulatory, quality, GxP,
pre-clinical/clinical, supply chain, manufacturing, CMC and product
launch. To learn more, visit us online at
http://www.tunnellconsulting.com.
Media Contact
Stephanie Haas, Tunnell
Consulting, 1 (610) 337- 0820,
stephanie.haase@tunnellconsulting.com
, https://tunnellconsulting.com/
View original content to download
multimedia:https://www.prweb.com/releases/steven-moscoe-joins-tunnell-consulting-as-principal-bringing-extensive-life-sciences-expertise-302185407.html
SOURCE Tunnell Consulting